Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Pliant Therapeutics is a biopharmaceutical company focused on discovering and developing therapies for fibrotic diseases. Its core pipeline includes oral small molecules targeting integrins to treat idiopathic pulmonary fibrosis, primary sclerosing cholangitis, and resistant solid tumors. The company leverages proprietary biology, medicinal chemistry, and biomarker tools to de-risk and accelerate fibrosis drug development for orphan and high unmet need indications.
This description was generated via AI from an annual report. Updated about 1 year ago.